Eric Jonasch, MD, presents the case of a 72-year-old male with advanced renal cell carcinoma (RCC) and discusses how recent data updates influence treatment decision-making.
EP. 4: CheckMate 9ER: Real World and Health-Related Quality of Life Outcomes
December 13th 2022Dr Jonasch shares his perspective on CheckMate 9ER in the real-world setting and discusses the trial’s health-related quality-of-life outcomes data investigating nivolumab plus cabozantinib in advanced renal cell carcinoma treatment.
Watch